Changes in Serum S100A12 and sRAGE Associated with Improvement of the PaO<sub>2</sub>/FiO<sub>2</sub> Ratio following PMX-DHP Therapy for Postoperative Septic Shock - Concepedia

Concepedia

Publication | Closed Access

Changes in Serum S100A12 and sRAGE Associated with Improvement of the PaO<sub>2</sub>/FiO<sub>2</sub> Ratio following PMX-DHP Therapy for Postoperative Septic Shock

12

Citations

25

References

2011

Year

Gaku Takahashi, Koichi Hoshikawa, Naoya Matsumoto, Tatsuyori Shozushima, Chiaki Onodera, Shigenori Kan, Shinji Akitomi, Tomohiro Kikkawa, Y Tomisawa, Masahiro Kojika,

European Surgical Research

Abstract

S100A12 is useful as a marker that reflected improvement in the PaO(2)/FiO(2) ratio after PMX-DHP. We consider PMX-DHP to be useful as adjunctive therapy for sepsis that reduces the Et and corrects the pathology in the early stage.

References

	Year	Citations

Page 1